AbbVie’s Contract Manufacturing Business has been serving our partners globally for more than 35 years. Our contract development and manufacturing capabilities span, Drug Product, Potent, Hot Melt Extrusion, Fermentation, Prefilled Syringes, Biologics, Packaging and Bulk Active Pharmaceutical Ingredients (APIs) across 9 production facilities in North America and Europe. You can contact us at www.abbviecontractmfg.com, by email abbviecontractmfg@abbvie.com or call us at 1-847-938-8524 to discuss what solutions we can offer to address your contract manufacturing needs.
Company name: AbbVie
Website:www.abbviecontractmfg.com
E-mail: abbviecontractmfg@abbvie.com
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.